Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.
about
Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesTreatment of chronic kidney diseases with histone deacetylase inhibitors.The real culprit in systemic lupus erythematosus: abnormal epigenetic regulation.Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus.HDAC expression and activity is upregulated in diseased lupus-prone mice.Epigenetics in systemic lupus erythematosusITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis.Epigenetic Aspects of Systemic Lupus Erythematosus.The nature of the GRE influences the screening for GR-activity enhancing modulators.Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases.Epigenetic drug discovery: breaking through the immune barrier.The acetyl code in rheumatoid arthritis and other rheumatic diseases.Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous.Therapeutic effects of histone deacetylase inhibitors on kidney disease.
P2860
Q26771812-486D52F6-4B0C-40CE-B134-8DA50E2FBD89Q35545347-7C4323B5-B7F6-4B77-AFE7-96B337853871Q35723616-3D71449B-1762-4E96-B30A-63E4A4871A5BQ36095555-0D20B5EE-F32D-40CB-853A-EC5AE72533ADQ36338516-EFBF088D-A1FE-4893-B6D9-6E5DAF64F795Q36524673-C909AC5F-E902-4D8B-BFF1-BAFB9A0170F0Q36569602-78BB24F8-59EE-42F0-A587-28152B775609Q36942972-A86C4359-EF5C-4964-B15C-57D82B22F2B7Q38697860-3F56D84C-5E5C-4BEC-AD9B-FA6D55290B66Q38968564-82BFD274-6461-45EF-831A-F2BEAFDB3F61Q38986705-43B1CB36-0F0C-44B1-88F7-04B106204243Q39094945-A8358076-F00E-4FED-AB77-DCDCECE45AACQ39456337-E2D474F9-768C-428B-8787-85BE0AA16614Q48136812-D39FD352-FAC6-4B95-94AB-C087CE77A2E1
P2860
Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Class I and II histone deacety ...... uces SLE pathogenesis in vivo.
@en
Class I and II histone deacety ...... uces SLE pathogenesis in vivo.
@nl
type
label
Class I and II histone deacety ...... uces SLE pathogenesis in vivo.
@en
Class I and II histone deacety ...... uces SLE pathogenesis in vivo.
@nl
prefLabel
Class I and II histone deacety ...... uces SLE pathogenesis in vivo.
@en
Class I and II histone deacety ...... uces SLE pathogenesis in vivo.
@nl
P2093
P2860
P1433
P1476
Class I and II histone deacety ...... uces SLE pathogenesis in vivo.
@en
P2093
Abdul G Puthiyaveetil
Christopher M Reilly
Cristen B Chafin
David L Caudell
Nicole L Regna
Sarah E Hammond
P2860
P356
10.1016/J.CLIM.2014.01.002
P577
2014-01-15T00:00:00Z